Jan 9 (Reuters) - Intra-Cellular Therapies Inc ITCI.O :
* INTRA-CELLULAR THERAPIES INC - ON JANUARY 5, ENTERED INTO
A NEW
SUPPLY AGREEMENT WITH SIEGFRIED AG
* INTRA-CELLULAR THERAPIES INC - INITIAL TERM OF THE
SIEGFRIED
AGREEMENT EXTENDS FOR THREE YEARS UNTIL JANUARY 5, 2026
* INTRA-CELLULAR THERAPIES- UNDER AGREEMENT, SIEGFRIED TO
MANUFACTURE, SUPPLY ACTIVE PHARMACEUTICAL INGREDIENT USED IN
CAPLYTA IN COMMERCIAL QUANTITIES
* INTRA-CELLULAR THERAPIES - UNDER AGREEMENT, PURCHASE
PRICES FOR
SUPPLY OF PRODUCT FROM SIEGFRIED SPECIFIED PRICES BASED ON
VOLUME OF PRODUCT PRODUCED
Further company coverage: ITCI.O
((reuters.briefs@thomsonreuters.com;))